Cross-Sector entity

Columbia Asia

Company
7

Every one of those 1 sits in a single category, ipo. Columbia Asia is most often covered alongside AMRI Hospitals, which appears in 1 of these 1 story. We currently track 1 Cross-Sector story that mention Columbia Asia, all published on March 24, 2026.

1 verified story tracked

Last mentioned: Mar 24, 2026

Entity pulse

Recent coverage · Columbia Asia

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Columbia Asia

Every one of those 1 sits in a single category, ipo. Columbia Asia is most often covered alongside AMRI Hospitals, which appears in 1 of these 1 story. We currently track 1 Cross-Sector story that mention Columbia Asia, all published on March 24, 2026. Each carries 2 original sources on average.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Columbia Asia. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Manipal integrates acquisitions of Columbia Asia and AMRI Hospitals to expand its footprint.

  2. Manipal Health officially files the Draft Red Herring Prospectus (DRHP) for an $852M IPO.

  3. Temasek Majority Stake

    Temasek acquires a majority stake in Manipal Health, valuing the company at $5 billion.

Stories mentioning Columbia Asia 1

Startups ipo Positive 7

Manipal Health Files for $852M IPO, Marking Major Exit for Temasek

Manipal Health Enterprises, one of India's largest multi-specialty healthcare chains, has officially filed for an initial public offering seeking to raise approximately $852 million. The move represents a significant liquidity event for majority shareholder Temasek and signals a robust appetite for healthcare infrastructure in the Indian public markets.

2 sources